Antimigraine drug, zolmitriptan, inhibits high-voltage activated calcium currents in a population of acutely dissociated rat trigeminal sensory neurons

Molecular Pain

Volumn 2, Issue , 2006, Pages

  Morikawa, Tomoko ^a,b   Matsuzawa, Yoshiyasu ^a,b   Makita, Koshi ^a   Katayama, Yoshifumi ^b  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMIGRAINE AGENT; BARIUM ION; CALCIUM CHANNEL BLOCKING AGENT; N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE; NEUROTRANSMITTER; PERTUSSIS TOXIN; SEROTONIN 1B RECEPTOR; SEROTONIN 1D RECEPTOR; TRIPTAN DERIVATIVE; VOLTAGE GATED CALCIUM CHANNEL; ZOLMITRIPTAN; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; BARIUM; CALCIUM; CALCIUM CHANNEL; GUANINE NUCLEOTIDE BINDING PROTEIN; OXAZOLIDINONE DERIVATIVE; TRYPTAMINE DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM CURRENT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; SENSITIVITY ANALYSIS; SENSORY NERVE CELL; TRIGEMINAL NERVE; ANIMAL; CALCIUM SIGNALING; CELL MEMBRANE POTENTIAL; DOSE RESPONSE; DRUG EFFECT; ELECTROPHYSIOLOGY; METABOLISM; METHODOLOGY; SENSORY RECEPTOR; WISTAR RAT;

ANIMALS; BARIUM; CALCIUM; CALCIUM CHANNELS; CALCIUM SIGNALING; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHYSIOLOGY; GTP-BINDING PROTEINS; MEMBRANE POTENTIALS; NEUROTRANSMITTER AGENTS; OXAZOLIDINONES; RATS; RATS, WISTAR; SENSORY RECEPTOR CELLS; TRIGEMINAL NERVE; TRYPTAMINES;

EID: 33646418739     PISSN: 17448069     EISSN: None     Source Type: Journal    
DOI: 10.1186/1744-8069-2-10     Document Type: Article

References (29)

1. Goadsby PJ, Edvinsson L: The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats. Ann Neurol 1993, 33:48-56.
2. IB-immunoreactivity within the human trigemino-cerebrovascular system: implications for the discovery of new antimigraine drugs. Cephalalgia 1997, 17:833-842.
3. ID receptor messenger RNA and ligand binding sites in guinea-pig brain and trigeminal ganglion: clues for function. Neuroscience 1998, 82:469-484.
4. Potrebic S, Ahn AH, Skinner K, Fields HL, Basbaum AI: Peptidergic nociceptors of both trigeminal and dorsal root ganglia express serotonin ID receptors: implications for the selective antimigraine action of triptans. J Neurosci 2003, 23:10988-10997.
5. ID receptors and substance P in trigeminal ganglion neurons in rats. Eur J Neurosci 2001, 13:2099-2104.
6. IB/ID) receptors. Br J Pharmocol 1997, 122:918-922.
7. IB/ID receptor agonists. Proc Natl Acad Sci USA 2004, 101:4274-4279.
8. 2+ channels in trigeminal ganglion neurons from neonatal rats. Life sciences 2003, 73:1175-1187.
9. Akerman S, Williamson DJ, Goadsby PJ: Voltage-dependent calcium channels are involved in neurogenic dural vasodilatation via a presynaptic transmitter release mechanism. Br J Pharmacol 2003, 140:558-566.
10. ID receptors in spinal neurons of Xenopus larvae. J Physiol 1998, 510:103-120.
11. 2+ channels. J Neurosci 1999, 19:890-899.
12. IB/ID receptor agonists. Arch Neurol 2002, 59:1084-1088.
13. Zgombick JM, Borden LA, Cochran TL, Kucharewicz SA, Weinshank RL, Branchek TA: Dual coupling of cloned human 5-hydroxytryptamineID alpha and 5-hydroxytryptamineID beta receptors stably expressed in murine fibroblasts: inhibition of adenylate cyclase and elevation of intracellular calcium concentrations via pertussis toxin-sensitive G protein(s). Mol Pharmacol 1993, 44:575-582.
14. IF receptor to multiple signal transduction pathways. Naunyn Schmiedebergs Arch Pharmacol 1993, 348:566-575.
15. Holz GG, Rane SG, Dunlap K: FTP-binding proteins mediate transmitter inhibition of voltage-dependent calcium channels. Nature 1986, 319:670-672.
16. Dolphin AC: G protein Modulation of Voltage-gated Calcium Channels. Pharmacological Reviews 2003, 55:607-627.
17. Durham PL, Russo AF: Stimulation of the calcitonin generelated peptide enhancer by mitogen-activated protein kinases and repression by an antimigraine drug in trigeminal ganglia neurons. J Neurosci 2003, 23:807-815.
18. Pietrobon D, Striessnig J: Neurobiology of migraine. Nature Reviews 2003, 4:386-398.
19. Ebersberger A, Portz S, Meissner W, Schaible HG, Richter F: Effects of N-, P/Q- and L-type calcium channel blockers on nociceptive neurones of the trigeminal nucleus with input from the dura. Cephalalgia 2004, 24:250-261.
20. Hong KW, Kim CD, Rhim BY, Lee WS: Effect of omega-conotoxin GVIA and omega-agatoxin IVA on the capsaicin-sensitive calcitonin gene-related peptide release and autoregulatory vasodilation in rat pial arteries. J Cereb Blood Flow Metab 1999, 19:53-60.
21. Asakura K, Kanemasa T, Minagawa K, Kagawa K, Yagami T, Nakajima M, Ninomiya M: alpha-eudesmol, a P/Q-type Ca (2+) channel blocker, inhibits neurogenic vasodilation and extravasation following electrical stimulation of trigeminal ganglion. Brain Res 2000, 873:94-101.
22. Soeda H, Tatsumi H, Katayama Y: Neurotransmitter release from growth cones of rat dorsal root ganglion neurons in culture. Neuroscience 1997, 77:1187-1199.
23. Sutton KG, Martin DJ, Pinnock RD, Lee K, Scott RH: Gabapentin inhibits high-threshold calcium channel currents in cultured rat dorsal root ganglion neurones. Br J Pharmacol 2002, 135:257-265.
24. McDowell TS: Fentanyl decreases Ca2+ currents in a population of capsaicin-responsive sensory neurons. Anesthesiology 2003, 98:223-231.
25. Kamp MA, Krieger A, Henry M, Hescheler J, Weiergraber M, Schneider T: Presynaptic 'Ca2.3-containing' E-type Ca channels share dual roles during neurotransmitter release. Eur J Neurosci 2005, 21:1617-1625.
26. Iwasaki S, Momiyama A, Uchitel OD, Takahashi T: Developmental changes in calcium channel types mediating central synaptic transmission. J Neurosci 2000, 20:59-65.
27. Borgland SL, Connor M, Christie MJ: Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J Physiol 2001, 536:35-47.
28. Strassman AM, Levy D: The anti-migraine agent sumatriptan induces a calcium-dependent discharge in meningeal sensory neurons. Neuroreport 2004, 15:1409-1412.
29. Datte JY, Offoumou MA: Involvement of nitric oxide in fading of 5-hydroxytryptamine-induced vasocontraction in rat isolated vena portae smooth muscle. J Pharm Pharm Sci 2004, 23:1-7.